A detailed history of Bridgefront Capital, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Bridgefront Capital, LLC holds 24,800 shares of BAX stock, worth $859,072. This represents 0.35% of its overall portfolio holdings.

Number of Shares
24,800
Holding current value
$859,072
% of portfolio
0.35%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $815,175 - $1.08 Million
24,800 New
24,800 $829,000
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $386,988 - $475,345
12,204 New
12,204 $471,000
Q2 2022

Aug 12, 2022

SELL
$63.83 - $80.0 $605,172 - $758,480
-9,481 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$76.85 - $89.45 $728,614 - $848,075
9,481 New
9,481 $735,000
Q4 2021

Feb 10, 2022

SELL
$74.57 - $87.19 $400,664 - $468,471
-5,373 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$73.77 - $83.61 $396,366 - $449,236
5,373 New
5,373 $432,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.